A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, the specs are claimed to "fill in" the missing section of the wearer's ...

Myopia, or nearsightedness, is a common eye condition. More than 40% of Americans can't see clearly at a distance because their eye is longer than normal. Usually myopia doesn't cause any problems ...

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million ...

Many of us are painfully aware of our body's increasing number of shortcomings as we get older. Sagging skin, hearing loss, receding hairlines and tending to use the bathroom more frequently than we ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

If you don't like getting needles in the arm, imagine getting them in your eyes. That's what people with wet age-related macular degeneration have to do, but thanks to new research, those injections ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye, and it marks the first of a three-part series on dry ...

Syfovre, also known as pegcetacoplan, is a medicine used to treat geographic atrophy, which is the advanced form of dry age-related macular degeneration. Geographic atrophy can cause irreversible ...

Preliminary studies suggest GLP-1s may offer long-term protection against the eye disease AMD for people without diabetes.

Anti–vascular endothelial growth factor (VEGF) medications have been a mainstay of treatment for wet age-related macular degeneration (wet AMD) for 20 years — and for good reason. The medication has ...

Diabetes is the leading cause of vision loss in people between 18 and 64 years old, according to the American Diabetes Association — and the best way to prevent this is to control blood sugar levels.